Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Seido Capital is a venture capital firm founded in 2024 and based in North America. The firm focuses on supporting innovators in life sciences and deep tech, providing capital, strategy, and expertise to help turn ideas into market leaders. With an AUM of $150 million, Seido Capital is positioned to make significant investments across various stages of company development.
The firm has a clear commitment to investing in pioneering technologies, particularly in sectors such as biotech, medical devices, diagnostics, and digital health tools. Seido Capital aims to leverage cross-border partnerships to ensure sustainable growth for its portfolio companies.
Seido Capital invests in life sciences and deep tech companies at various stages, including pre-seed, seed, Series A, Series B, Series C, pre-IPO, and IPO. The firm emphasizes sectors such as biotech, medical devices, diagnostics, and digital health tools. Their investment strategy is designed to support pioneering technologies and data-driven solutions.
Seido Capital looks for founders who are innovators in their fields and who demonstrate a strong vision for their companies. The firm values data-driven approaches and aims to partner with startups that have the potential to become market leaders. Their deal structure preferences include flexible terms that align with the growth trajectories of their portfolio companies.
Seido Capital's portfolio includes companies involved in cutting-edge diagnostics, digital therapeutics, and transformative AI technologies. While specific names and descriptions of portfolio companies were not provided, the firm is known for backing innovators that are at the forefront of technological advancements in healthcare.
Investments in diagnostics and digital health tools highlight Seido Capital's commitment to improving patient outcomes and enhancing healthcare delivery. The firm’s focus on AI technologies further underscores its dedication to supporting companies that are reshaping the future of healthcare through innovative solutions.
Olivier Belenger - Managing Partner. Olivier has a background in venture capital and has led numerous investments in the life sciences and deep tech sectors. His expertise includes identifying promising technologies and guiding startups through their growth phases.
To pitch Seido Capital, founders should visit their website and submit their proposals through the provided channels. A well-structured pitch deck should include details about the business model, market opportunity, and technological innovation. Response times may vary, so founders should be prepared for a potential wait.
What are Seido Capital's investment criteria?
Seido Capital invests in life sciences and deep tech companies at various stages, from pre-seed to IPO. They focus on sectors such as biotech, medical devices, diagnostics, and digital health tools.
How can I pitch to Seido Capital?
Founders can pitch to Seido Capital by visiting their website at Seido Capital's website. They encourage submissions that clearly outline the business model, market opportunity, and technological innovation.
What makes Seido Capital different from other investors?
Seido Capital emphasizes a hands-on approach, providing not just capital but also strategic guidance and expertise to help startups grow. Their focus on life sciences and deep tech sets them apart in the venture capital landscape.
What is the geographic focus of Seido Capital?
Seido Capital primarily invests in North America, targeting companies that are innovating in life sciences and deep tech sectors.
What is the typical check size for investments?
While specific check sizes are not disclosed, Seido Capital invests across various stages, indicating flexibility in their funding approach to meet the needs of different startups.
What kind of post-investment support does Seido Capital provide?
Seido Capital offers operational support, strategic guidance, and access to their network to help portfolio companies scale effectively.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.